Nirma's acquisition of majority stake in Glenmark Life Sciences to make Glenmark Pharma debt-free
Glenmark Pharmaceuticals has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences at a price of Rs 615 per share.
Source: businesstoday.in